Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

84.05 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
This Starbucks Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
Expert Outlook: Illumina Through The Eyes Of 13 Analysts
Via Benzinga
Wall Street Poised For Second Day Of Gains While Bank Of Japan Makes Reassurances; Dollar Strengthens Against Yen, Crude Prices Surge: What's Driving Markets Wednesday?
The U.S. 
Via Benzinga
Illumina Analysts Increase Their Forecasts Following Strong Q2 Results
Via Benzinga
Peering Into Illumina's Recent Short Interest
Via Benzinga
$1000 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
US Stocks Set To Extend Gains Despite Mixed Earnings, VIX Dips Back Toward Pre-Sell-Off Levels: Analyst Says Pullback Is A 'Growth Scare' And Not 'Calamity'
Wall Street could go from strength to strength as the index futures point to another session in the green as investors seek to put the worst behind. Volatility continued to drop, as evidenced by... 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
A Glimpse Into The Expert Outlook On Illumina Through 10 Analysts
Via Benzinga
ILMN Stock Earnings: Illumina Misses EPS, Beats Revenue for Q2 2024
ILMN stock results show that Illumina missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Wall Street Rebounds After Selloff, VIX Falls, Dollar Surges Against Yen: What's Driving Markets Tuesday?
U.S. stock markets saw a strong recovery on Tuesday, with both the S&P 500 and the Nasdaq 100 climbing over 2%, nearly offsetting Monday’s losses. Investors took advantage of recent volatility to buy... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Second-Quarter 2024 Thematic Growth Update
The second quarter saw stocks move higher again, reaching levels that seem overly stretched from a fundamental and technical standpoint. The market has seen a significant rotation into mega-cap stocks,... 
Via Talk Markets
US Stocks Set To Open Higher After Monday's Crash, VIX Plummets: Analyst Says Would Have Worried If Market Surged Higher Without Correction
Strong sell-off may be viewed as an opportunity to load up beaten-down stocks but traders may seek evidence regarding sustainability of uptrend. 
Via Benzinga
Topics Stocks
Exposures US Equities
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks." 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper highlights five stocks seeing increased interest across the Benzinga ecosystem using proprietary data. 
Via Benzinga
3 Precision Medicine Stocks Tailoring Treatments
With technological developments pushing the boundaries of healthcare, these are the precision medicine stocks to consider. 
Via InvestorPlace
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences. 
Via MarketBeat
3 Spinoff Stocks You Should Buy Now: July 2024
Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early. 
Via InvestorPlace
What's Going On With 10x Genomics Stock On Wednesday?
Illumina acquires Fluent BioSciences to enhance single-cell analysis and multiomics research. 10x Genomics faces challenges as shares drop amid competitive pricing pressures in the single-cell market. 
Via Benzinga
Illumina Buys Fluent BioSciences To Gain Stronger Foothold In Single-Cell Analysis
Illumina has acquired Fluent BioSciences, enhancing its single-cell analysis and multiomics capabilities. Fluent's innovative technology, including the PIPseq V system, offers cost-effective and... 
Via Benzinga
SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
3 Of the Best ETFs to Buy for AI Stocks Exposure
One of the best ways to gain max exposure to the unstoppable artificial intelligence boom is with popular AI ETFs. 
Via InvestorPlace
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
The 3 Best Gene Editing Stocks to Buy in July 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks. 
Via InvestorPlace
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies. 
Via InvestorPlace
GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today
New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock. 
Via InvestorPlace
Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ
Illumina spins off Grail, making Grail an independent public company. Shareholders receive one GRAIL share per six Illumina shares. Illumina retains a 14.5% stake. 
Via Benzinga
Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months - Sunday, June 23
Over the past twelve months, 10 large-cap stocks have underperformed all others. Here's a brief look at these underperforming stocks. 
Via Talk Markets
3 Stocks to Buy That Are NOT in the S&P 500 (but Should Be)
Companies not yet in the S&P 500 but whose businesses are doing well make excellent stocks to buy. Here are three examples. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.